Department of Radiology

Publications

2023

Fassia M-, Charalel R, Talenfeld AD. Demonstrating the Value of Interventional Radiology. Semin Intervent Radiol. 2023;40(5):403-406.

Koweek L, Achenbach S, Berman DS, J Carr J, Cury RC, Ghoshhajra B, et al. Standardized Medical Terminology for Cardiac Computed Tomography 2023 Update. Radiol Cardiothorac Imaging. 2023;5(4):e230167.

Hughes DR, Espinoza W, Fein S, Rula EY, McGinty G. Patient Cost-Sharing and Utilization of Breast Cancer Diagnostic Imaging by Patients Undergoing Subsequent Testing After a Screening Mammogram. JAMA Netw Open. 2023;6(3):e234893.

Dawd JE, Ozsahin DU, Ozsahin I. DEVELOPING DIAGNOSTIC REFERENCE LEVELS FOR CT EXAMINATIONS IN ADDIS ABABA, ETHIOPIA. Radiat Prot Dosimetry. 2023;199(3):ncac263 235 245.

Shahidi R, Baradaran M, Asgarzadeh A, Bagherieh S, Tajabadi Z, Farhadi A, et al. Diagnostic performance of MRI radiomics for classification of Alzheimer's disease, mild cognitive impairment, and normal subjects: a systematic review and meta-analysis. Aging Clin Exp Res. 2023;35(11):2333-2348.

Gaudino M, Di Franco A, Arbustini E, Bacha E, Bates ER, Cameron DE, et al. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review. Ann Thorac Surg. 2023;116(6):1124-1141.

Motovilova E, Aronowitz E, Vincent J, Shin J, Tan ET, Robb F, et al. Silicone-based materials with tailored MR relaxation characteristics for use in reduced coil visibility and in tissue-mimicking phantom design. Med Phys. 2023;50(6):3498-3510.

Adams AR, Li X, Byanyima JI, Vesslee SA, Nguyen TD, Wang Y, et al. Peripheral and Central Iron Measures in Alcohol Use Disorder and Aging: A Quantitative Susceptibility Mapping Pilot Study. Int J Mol Sci. 2023;24(5).

Kiser K, Zhang J, Kim SG. Textural Features of Mouse Glioma Models Measured by Dynamic Contrast-Enhanced MR Images with 3D Isotropic Resolution. Tomography. 2023;9(2):721-735.

Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, et al. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2023;50(9):2830-2845.